Cognitive Measures in Pediatric Drug Development: Key Considerations, Tools and Technologies
November 16, 2015
The second podcast in our series – ‘Cognitive Measures in Pediatric Drug Development: Key Considerations, Tools and Technologies’ – sees Dr. Brian Harel, Clinical Science Director at Cogstate discussing the requirements of pharmaceutical companies by regulators to collect data on the effects of their treatments on children, and the challenge to find ways to minimize the time, risk and complexity of these studies.
